Cargando…
Paclitaxel Suppresses Hepatocellular Carcinoma Tumorigenesis Through Regulating Circ-BIRC6/miR-877-5p/YWHAZ Axis
BACKGROUND: Paclitaxel is an effective chemotherapeutic agent for the treatment of cancer patients. Accumulating evidence suggests that circular RNAs (circRNAs) play critical roles in the occurrence and development of human cancers. However, there are few studies on interactions between paclitaxel a...
Autores principales: | Liu, Yi, Guo, Jianchao, Shen, Ka, Wang, Renlong, Chen, Cheng, Liao, Zhiyuan, Zhou, Jianbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519811/ https://www.ncbi.nlm.nih.gov/pubmed/33061425 http://dx.doi.org/10.2147/OTT.S261700 |
Ejemplares similares
-
Circ_0069094 regulates malignant phenotype and paclitaxel resistance in breast cancer cells via targeting the miR‐136‐5p/YWHAZ axis
por: Kong, Zhihua, et al.
Publicado: (2023) -
The ASH1-miR-375-YWHAZ Signaling Axis Regulates Tumor Properties in Hepatocellular Carcinoma
por: Zhao, Juan-Feng, et al.
Publicado: (2018) -
Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer
por: Wang, Wenrui, et al.
Publicado: (2017) -
CircANKRD52 Promotes the Tumorigenesis of Hepatocellular Carcinoma by Sponging miR-497-5p and Upregulating BIRC5 Expression
por: Zhang, Mingzhi, et al.
Publicado: (2021) -
Circular RNA circNHSL1 Contributes to Gastric Cancer Progression Through the miR-149-5p/YWHAZ Axis
por: Hui, Chunying, et al.
Publicado: (2020)